United StatesÚltimas notícias

Consensus Cloud Solutions (NASDAQ:CCSI) reported preliminary fourth-quarter results on Tuesday.

Biofrontera (NASDAQ:BFRI) has achieved a significant clinical milestone, announcing that its Phase 3 trial of Ameluz® photodynamic therapy (PDT) met its primary endpoint for the treatment of mild-to-moderate actinic keratoses (AK) located on the extremities, neck, and trunk.

Autodesk (NASDAQ:ADSK) has initiated a high-stakes legal battle against Alphabet (NASDAQ:GOOGL), filing a trademark infringement lawsuit in San Francisco federal court on February 6, 2026.

Telehealth provider Hims & Hers Health (NYSE:HIMS) transitioned from a marketing high to a legal defense on February 9, 2026, as Danish pharmaceutical giant Novo Nordisk (NYSE:NVO) filed a lawsuit alleging patent infringement and deceptive marketing

Alexander’s (NYSE:ALX) reported a steep decline in financial performance for the final quarter of 2025, with both net income and funds from operations (FFO) falling well below prior-year levels.

YY Group Holding (NASDAQ:YYGH) has reported a significant expansion of its balance sheet, with unaudited total assets reaching approximately $44 million as of June 30, 2025.

XTI Aerospace (NASDAQ:XTIA) has outlined a robust financial outlook for fiscal year 2026, projecting revenue to exceed $160 million as the company integrates its November 2025 acquisition of Drone Nerds.

KBR (NYSE:KBR) has been awarded two firm-fixed-price task orders totaling $103 million to support the United States Space Force, further cementing the engineering and technology firm's role in defense data strategy.

Cango (NYSE:CANG) has completed the sale of 4,451 Bitcoin for approximately $305 million, a move designed to strengthen the company’s balance sheet as it executes a sweeping strategic pivot from pure-play digital assets toward distributed artificial intelligence infrastructure.

MannKind (NASDAQ:MNKD) announced a major clinical milestone Monday, enrolling the first patient in its INHALE-1ST study just as it prepares for a transformative FDA decision that could introduce the first needle-free insulin for children in over a century.

Apollo Global Management (NYSE:APO) delivered a powerhouse performance for 2025, topping analyst expectations with record-breaking capital deployment and fundraising that cements its position as a dominant force in the global private credit and retirement markets.

Inotiv (NASDAQ:NOTV) reported a mixed start to fiscal 2026, as robust demand for its Discovery and Safety Assessment (DSA) services was offset by ongoing restructuring costs and a contraction in its research models segment.